These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 16522164)

  • 1. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors.
    Yao CL; Hsu SC; Hwang SM; Lee WC; Chiou TJ
    Cytotherapy; 2013 Sep; 15(9):1126-35. PubMed ID: 23768928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ex vivo expansion of megakaryocyte progenitor cells for CD133(+) cells derived from human umbilical cord blood].
    Wang L; Chen DX; Fang N; Liu ZL; Zhang T; Wan WH; Qi Y; Liu JW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):645-9. PubMed ID: 18549646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
    Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
    Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
    Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
    Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
    Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
    J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.
    Boxall SA; Cook GP; Pearce D; Bonnet D; El-Sherbiny YM; Blundell MP; Howe SJ; Leek JP; Markham AF; de Wynter EA
    Bone Marrow Transplant; 2009 Apr; 43(8):627-35. PubMed ID: 18997827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low oxygen tension favored expansion and hematopoietic reconstitution of CD34(+) CD38(-) cells expanded from human cord blood-derived CD34(+) Cells.
    Wang Z; Du Z; Cai H; Ye Z; Fan J; Tan WS
    Biotechnol J; 2016 Jul; 11(7):945-53. PubMed ID: 26997358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC.
    Forraz N; Pettengell R; McGuckin CP
    Stem Cells; 2004; 22(1):100-8. PubMed ID: 14688396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.